IRQ Articles

SIR Today homepage 

12-17-2020 15:37

SIR Today 2022 banner
Welcome to SIR Today, your guide to the events, programming and faculty that make the SIR annual meeting a memorable meeting for the interventional radiology community each year. Watch for more preview content to be published in the coming weeks, as well as daily previews and recaps of scientific sessions, award presentations, and during the week of the meeting in June. For the latest details on presenters, times and locations, refer to the SIR 2022 website and the annual meeting mobile app.

Other SIR 2022 coverage

Previews: Tuesday, May 10 | Tuesday, May 31

 | 
Monday, June 13 | Tuesday, June 14

Watch for an SIR 2022 recap on Tuesday, July 12!


Note: New this year: Live-streamed plenaries

Tune in Sunday, June 12, through Wednesday, June 15, at 10:30 a.m. for the live streaming of our daily plenaries, which bring together the SIR community to honor luminaries, highlight research and hear from experts on topics impacting the specialty.


Celebrate JVIR and IR trivia at the Tuesday Plenary

Posted June 14, 2022

Come celebrate the accomplishments and culture of IR in today’s plenary, held at 10:30 a.m. in the Ballroom. Join Journal of Vascular and Interventional Radiology (JVIR) Editor-in-chief Daniel Y. Sze, MD, PhD, FSIR, as he recognizes award-winning JVIR authors and reviewers, followed by the always-entertaining Film Panel. Read | Live stream the awards

 



“Have you ever wondered why you never see speeches about paths to leadership for men?” asked Melina R. Kibbe, MD, FACS, FAHA, as she delivered the 2022 SIR Women in Interventional Radiology (WIR) Section InspIRed Lecture at Monday’s WIR Luncheon. The luncheon also featured 2022 WIR Champion Award recipient Kari J. Nelson, MD, FSIR. Read

SIR Foundation brings community together at 2022 Gala

Watch for more pictures and details from the 2022 SIR Foundation Gala in the Summer 2022 IR Quarterly.

Attendees were moved by videos of
UFE and other patient stories.
SIR and SIR Foundation leadership joined in the
energetic celebration of IR research.

Abstracts of the Year preview: Potential new IR treatment for lumbar disc herniations

Posted June 14, 2022

Interventional radiologists may provide a more effective and minimally invasive treatment for lumbar disc herniations typically treated by open surgery, according to data from a recent European multicenter pilot trial. Read



Physicians may be able to identify several new biomarkers related to immune activation to aid in patient selection for radioembolization of breast cancer liver metastasis, according to data in “Immune activation markers and response to radioembolization of breast cancer liver metastasis: Pilot study.” Read



Abstracts of the Year preview: Y-90 as first-line treatment for intrahepatic cholangiocarcinoma

Posted June 14, 2022

Radioembolization can be considered as first-line treatment for unresectable intrahepatic cholangiocarcinoma (ICH), according to data that will be presented in a Wednesday Abstract of the Year. Read

Abstracts of the Year preview: Y-90 radioembolization of colorectal cancer metastatic to the liver

Posted June 14, 2022

Yttrium-90 (Y-90) microsphere embolization, when deployed as part of second-line therapy, contributed to overall survival in patients with colorectal liver metastases, according to data from the RESiN registry. Read

Researchers successfully created a sheep model that mimics knee osteoarthritis in humans, which will allow IRs to better understand geniculate artery embolization (GAE). Read

Featured Abstract preview: Combination of chemo and TARE used to bridge liver cancer patients to surgery

Posted June 14, 2022

University of Chicago interventional radiologists collaborated with several specialties to combine treatment to improve the prognosis of patients with intrahepatic cholangiocarcinoma (iCCA). Read

Featured abstract preview: AI model could diagnose liver cancer much earlier in cirrhosis patients

Posted June 14, 2022

Using an AI model that combines patient images and prognostic biomarker information could improve early diagnosis of hepatocellular carcinoma (HCC) among cirrhosis patients. Read

Featured abstract preview: New targeted ablation technique may improve immunotherapy in liver cancer

Posted June 14, 2022

Immunotherapy has been an exciting development to treat various cancers. Unfortunately, it is not that effective in patients with hepatocellular carcinoma (HCC) because of the high rates of cirrhosis. But a research team at the MD Anderson Cancer Center has developed a new technique that may improve the effectiveness of immunotherapy in HCC. Read

View the interactive SIR Today preview of the SIR 2022 Annual Scientific Meeting
View the archive of prior years' SIR Today articles

ADVERTISEMENT ADVERTISEMENT

Connect with SIR

AD: Medtronic

ADVERTISEMENT